Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 1, 2009, Pages 75-80

  Solomon, Alina ^a,b   Kivipelto, Miia ^a,b   Wolozin, Benjamin ^c   Zhou, Jufen ^d   Whitmer, Rachel A ^d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DIVISION OF RESEARCH   (United States)

Author keywords

Alzheimer's dementia; Cholesterol; Dementia; Epidemiology; Vascular dementia

Indexed keywords

CHOLESTEROL;

ADULT; AFRICAN AMERICAN; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; ASIAN; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; DIABETES MELLITUS; EDUCATION; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RACE; RISK FACTOR; STROKE;

ADULT; AGED; ALZHEIMER DISEASE; CHOLESTEROL; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DEMENTIA, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SOCIOECONOMIC FACTORS;

EID: 67749114631     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000231980     Document Type: Article

References (22)

1. Kivipelto M, Solomon A: Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence. Acta Neurol Scand Suppl 2006;185:50-57. (Pubitemid 44015225)
2. Notkola IL, Sulkava R, Pekkanen J, et al: Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer's disease. Neuroepidemiology 1998;17:14-20. (Pubitemid 28153361)
3. Kivipelto M, Helkala EL, Laakso MP, et al: Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 2002;137:149-155. (Pubitemid 34827510)
4. Kalmijn S, Foley D, White L, et al: Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000;20:2255-2260. (Pubitemid 30777782)
5. Tan ZS, Seshadri S, Beiser A, et al: Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med 2003;163:1053-1057. (Pubitemid 36548931)
6. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K: Midlife cardiovascular risk factors and risk of dementia in late-life. Neurology 2005;64:277-281.
7. Krieger N: Overcoming the absence of socio-economic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;82:703-710.
8. Collen MF: Multiphasic Health Testing Services. New York, John Wiley & Sons, 1978.
9. Collen MF, Davis LF: The multitest laboratory in health care. J Occup Med 1969;11: 355-360.
10. Iribarren C, Sidney S, Sternfeld B, Browner WS: Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 2000;283:2810-2815. (Pubitemid 30387825)
11. Arellano MG, Petersen GR, Petitti DB, Smith RE: The California Automated Mortality Linkage System (CAMLIS). Am J Public Health 1984;74:1324-1330.
12. National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report (NIH Publication No. 02-5215). Bethesda, National Heart, Lung and Blood Institute, National Institutes of Health, 2002.
13. Solomon A, Kåreholt I, Ngandu T, et al: Serum cholesterol changes after midlife and late-life cognition: 21-year follow-up study. Neurology 2007;68:751-756. (Pubitemid 46667900)
14. Stewart R, White LR, Xue QL, Launer LJ: Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2007;64:103-107. (Pubitemid 46072431)
15. Bjorkhem I: Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 2006; 260:493-508.
16. Hachinski V, Iadecola C, Petersen RC, et al: National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006;37:2220-2241. (Pubitemid 44337162)
17. Romero JR: Prevention of ischemic stroke: overview of traditional risk factors. Curr Drug Targets 2007;8:794-801. (Pubitemid 47163389)
18. He K, Xu Y, van Horn L: The puzzle of dietary fat intake and risk of ischemic stroke: a brief review of epidemiologic data. J Am Diet Assoc 2007;107:287-295. (Pubitemid 46136126)
19. Rockwood K: Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease. Acta Neurol Scand Suppl 2006;185:71-77. (Pubitemid 44015228)
20. Aguero-Torres H, Kivipelto M, von Strauss E: Rethinking the dementia diagnoses in a population-based study: what is Alzheimer's disease and what is vascular dementia? A study from the Kungsholmen project. Dement Geriatr Cogn Disord 2006;22:244-249. (Pubitemid 44310521)
21. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J: Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006;5:735-741. (Pubitemid 44205512)
22. Hachinski V: Stroke and vascular cognitive impairment: a transdisciplinary, translational and transactional approach. Stroke 2007;38:1396-1403.